Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00492258
Recruitment Status : Completed
First Posted : June 27, 2007
Last Update Posted : August 12, 2013
Sponsor:
Information provided by:
National Cancer Institute (NCI)